Article
Withaferin A activates TRIM16 for its anti-cancer activity in melanoma
12 Nov 2020
Abstract excerpt
Although selective BRAF inhibitors and novel immunotherapies have improved short-term treatment responses in metastatic melanoma patients, acquired resistance to these therapeutics still represent a major challenge in clinical practice. In this study, we evaluated the efficacy of Withaferin A (WFA), derived from the medicinal plant Withania Somnifera, as a novel therapeutic agent for the treatment of melanoma....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
